Trips On Antidepressant

Featured Health Expert
7399_1284
EXPERT

Depression, Adolescents, and Antidepressants

Earlier this month, the Food and Drug Administration (FDA) approved Lexapro (escitalopram oxalate) for the acute and maintenance treatment of major depressive disorder (MDD) in adolescents 12- to 17-years-old.

 

Here's some basic information about the approval from a Forest Laboratories press release (I have put some parts in bold for added attention):

"The approval of Lexapro for the treatment of adolescent depression was supported by two placebo-controlled studies, one conducted in...

Read more

More information on "Trips On Antidepressant"

From Our Experts

See more SharePosts »

From Our Sources

More on Depression »